256 related articles for article (PubMed ID: 22005032)
1. Hypertriglyceridemia secondary to obesity and diabetes.
Subramanian S; Chait A
Biochim Biophys Acta; 2012 May; 1821(5):819-25. PubMed ID: 22005032
[TBL] [Abstract][Full Text] [Related]
2. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
Ito MK
Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus.
Sniderman AD; Scantlebury T; Cianflone K
Ann Intern Med; 2001 Sep; 135(6):447-59. PubMed ID: 11560458
[TBL] [Abstract][Full Text] [Related]
4. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
5. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
Quispe R; Martin SS; Jones SR
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
[TBL] [Abstract][Full Text] [Related]
6. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
Yki-Järvinen H
Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
[TBL] [Abstract][Full Text] [Related]
7. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events.
McCullough PA; Ahmed AB; Zughaib MT; Glanz ED; Di Loreto MJ
Rev Cardiovasc Med; 2011; 12(4):173-85. PubMed ID: 22249508
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
10. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
11. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
12. Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease.
Kumar V; Madhu SV; Singh G; Gambhir JK
J Assoc Physicians India; 2010 Oct; 58():603-7. PubMed ID: 21510110
[TBL] [Abstract][Full Text] [Related]
13. [Diabetic dyslipoproteinemia].
Geiss HC; Parhofer K
MMW Fortschr Med; 2006 Apr; 148(14):30-3. PubMed ID: 16669277
[TBL] [Abstract][Full Text] [Related]
14. A physician's guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy.
Klop B; Wouter Jukema J; Rabelink TJ; Castro Cabezas M
Panminerva Med; 2012 Jun; 54(2):91-103. PubMed ID: 22525564
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
17. [Atherogenic dyslipidemia and the metabolic syndrome: pathophysiological mechanisms].
Zák A; Slabý A
Cas Lek Cesk; 2008; 147(9):459-70. PubMed ID: 18988488
[TBL] [Abstract][Full Text] [Related]
18. [Statin therapy for atherogenic hypertriglyceridemia].
Koba S
Nihon Rinsho; 2013 Sep; 71(9):1655-60. PubMed ID: 24205730
[TBL] [Abstract][Full Text] [Related]
19. Catabolism of lipoproteins and metabolic syndrome.
Therond P
Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):366-71. PubMed ID: 19474714
[TBL] [Abstract][Full Text] [Related]
20. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
